Slug and truncated tal1 reduce glioblastoma stem cell growth downstream of notch1 and define distinct vascular subpopulations in glioblastoma multiforme

Abstract

Glioblastomas (GBM) are high‐grade brain tumors, containing cells with distinct pheno-types and tumorigenic potentials, notably aggressive and treatment‐resistant multipotent glioblas-toma stem cells (GSC). The molecular mechanisms controlling GSC plasticity and growth have only partly been elucidated. Contact with endothelial cells and the Notch1 pathway control GSC proliferation and fate. We used three GSC cultures and glioma resections to examine the expression, reg-ulation, and role of two transcription factors, SLUG (SNAI2) and TAL1 (SCL), involved in epithelial to mesenchymal transition (EMT), hematopoiesis, vascular identity, and treatment resistance in var-ious cancers. In vitro, SLUG and a truncated isoform of TAL1 (TAL1‐PP22) were strongly upregu-lated upon Notch1 activation in GSC, together with LMO2, a known cofactor of TAL1, which formed a complex with truncated TAL1. SLUG was also upregulated by TGF‐β1 treatment and by co‐culture with endothelial cells. In patient samples, the full‐length isoform TAL1‐PP42 was expressed in all glioma grades. In contrast, SLUG and truncated TAL1 were preferentially overex-pressed in GBMs. SLUG and TAL1 are expressed in the tumor microenvironment by perivascular and endothelial cells, respectively, and to a minor extent, by a fraction of epidermal growth factor receptor (EGFR) ‐amplified GBM cells. Mechanistically, both SLUG and truncated TAL1 reduced GSC growth after their respective overexpression. Collectively, this study provides new evidence for the role of SLUG and TAL1 in regulating GSC plasticity and growth.